• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH TANGO OPTIMO; AUTOMATED BLOOD BANK ANALYSER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH TANGO OPTIMO; AUTOMATED BLOOD BANK ANALYSER SYSTEM Back to Search Results
Catalog Number 848 900 010
Device Problems False Negative Result (1225); Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/11/2017
Event Type  malfunction  
Manufacturer Narrative
This is our initial report on this incident.
 
Event Description
The customer reported discrepant test results on a patient sample known as anti-kell when testing on tango optimo.The sample showed initially negative test results with screening cell #1 (biotest cell 3).After recollecting the sample and testing it on the second testing day with biotest cell 3 , the sample showed a positive reaction (2+).They repeated two samples from the day before and obtained a +/- test on the screening cells.The customer returned the supposedly defective product (biotest cell 3), the used ahg for solid screen ii plates (scii) and the two samples that had caused the discrepant results for investigational testing.Our quality control laboratory tested the complained biotest cell 3 lot # 8727011-00 in comparison with the retained current lot biotest cell 3 # 8731021-00 with different samples, controls and with the patient samples provided by the customer.Additionally the ahg for sc ii was tested by titration in parallel to the retained sample and a reference lot.The patient samples were clearly identified to have an anti-kell.All positive and negative reactions were correct for antibody screen.We did not observe any false negative reaction.Testing by our quality control laboratory confirmed the correctly function of the allegedly defective lot biotest cell 3, #8727011-00.A review of the batch record documentation showed no irregularities which might have negative influences on the quality of the allegedly defective lot.Following our sop the complaint has to be classified as not confirmed because the allegedly defective product worked as expected and the provided samples were clearly identified to be positive for anti-kell.The affected tango optimo was inspected by one of our field service engineer.From today¿s perspective the affected tango optimo was confirmed to run within specifications.The root cause analysis is still ongoing.
 
Manufacturer Narrative
This is our final report on this incident.
 
Event Description
The customer reported discrepant test results on a patient sample known as anti-kell when testing on tango optimo.The sample showed initially negative test results with screening cell #1 (biotestcell 3).After recollecting the sample and testing it on the second testing day with biotestcell 3 , the sample showed a positive reaction (2+).They repeated two samples from the day before and obtained a +/- test on the screening cells.The customer returned the supposedly defective product (biotestcell 3), the used ahg for solidscreen ii plates (scii) and the two samples that had caused the discrepant results for investigational testing.Our quality control laboratory tested the complained biotestcell 3 lot # 8727011-00 in comparision with the retained current lot biotestcell 3 # 8731021-00 with different samples, controls and with the patient samples provided by the customer.Additionally the ahg for sc ii was tested by titration in parallel to the retained sample and a reference lot.The patient samples were clearly identified to have an anti-kell.All positive and negative reactions were correct for antibody screen.We did not observe any false negative reaction.Testing by our quality control laboratory confirmed the correctly function of the allegedly defective lot biotestcell 3, #8727011-00.A review of the batch record documentation showed no irregularities which might have negative influences on the quality of the allegedly defective lot.Following our sop the complaint has to be classified as not confirmed because the allegedly defective product worked as expected and the provided samples were clearly identified to be positive for anti-kell.The affected tango optimo was inspected by one of our field service engineers.It was confirmed that the instrument is working according to specification.The log file does not indicate an error during processing of the sample.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TANGO OPTIMO
Type of Device
AUTOMATED BLOOD BANK ANALYSER SYSTEM
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM  63303
Manufacturer (Section G)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM   63303
Manufacturer Contact
martina benkert
industriestrasse 1
dreieich, hessen 63303
GM   63303
MDR Report Key6854867
MDR Text Key86314270
Report Number9610824-2017-00066
Device Sequence Number1
Product Code KSZ
UDI-Device Identifier07611969961696
UDI-Public07611969961696
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK080013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 09/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number848 900 010
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/14/2017
Initial Date FDA Received09/11/2017
Supplement Dates Manufacturer Received08/14/2017
Supplement Dates FDA Received09/19/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-